Not Yet Recruiting PHASE3 INTERVENTIONAL 3-arm NCT06407401

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer; A Pragmatic Randomized Controlled Trial

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III Drug-Related Side Effects and Adverse Reactions ER+ Breast Cancer HER2-negative Breast Cancer Musculoskeletal Pain

Interventions Booklet for healthy behaviors Duloxetine 60 MG Furosemide 40 mg

Updated 4 times since 2024 Last updated: Nov 4, 2024 Started: Dec 31, 2024 Primary completion: Apr 18, 2028 Completion: Nov 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Breast Cancer Stage I and Breast Cancer Stage II, this trial is actively recruiting participants. The trial is conducted by European Organisation for Research and Treatment of Cancer - EORTC and has accumulated 4 data snapshots since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Dec 2024 — Present [monthly]

Not Yet Recruiting PHASE3
Sep 2024 — Dec 2024 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3
Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Organisation for Research and Treatment of Cancer - EORTC

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.